ScholarLens Back to search
2004•Modern Diagnosis and TreatmentRequires access

Value of Combined Detection of CA19-9 and CEA with Electrochemiluminescence in Diagnosis of Pancreatic Cancer

Chen Bing-hui

Open publisher page 0 citations

Abstract

Objective To investigate the clinical value of the tumor marker CA19-9 and carcinoembryonic antigen(CEA) in human serum in diagnosis of pancreatic cancer.Method The concentrations of CA19-9 and CEA in serum in thirty-two patients with pancreatic cancer and thirty-two patients with benign pancreatic disease were detected with Elecsys 1010 auto electrochemiluminescene immune analyzer.Results The levels of CA19-9 and CEA in the former group were 106.3±79.1ng/ml and 31.8±0.7ng/ml,which were significantly higher than those in the latter group.Conculsions The value of CA19-9 in diagnosis of pancreatic cancer is higher than that of CEA.But the combined detection of CA19-9 and CEA is clinically significant to diagnosis of pancreatic cancer.

About this research paper

What this paper is about

Objective To investigate the clinical value of the tumor marker CA19-9 and carcinoembryonic antigen(CEA) in human serum in diagnosis of pancreatic cancer.Method The concentrations of CA19-9 and CEA in serum in thirty-two patients with pancreatic cancer and thirty-two patients with benign pancreatic disease were detected with Elecsys 1010 auto electrochemiluminescene immune analyzer.Results The levels of CA19-9 and CEA in the former group were 106.3±79.1ng/ml and 31.8±0.7ng/ml,which were significantly higher than those in the latter group.Conculsions The value of CA19-9 in diagnosis of pancreatic cancer is higher than that of CEA.But the combined detection of CA19-9 and CEA is clinically significant to diagnosis of pancreatic cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical value of the tumor marker CA19-9 and carcinoembryonic antigen(CEA) in human serum in diagnosis of pancreatic cancer.Method The concentrations of CA19-9 and CEA in serum in thirty-two patients with pancreatic cancer and thirty-two patients with benign pancreatic disease were detected with Elecsys 1010 auto electrochemiluminescene immune analyzer.Results The levels of CA19-9 and CEA in the former group were 106.3±79.1ng/ml and 31.8±0.7ng/ml,which were significantly higher than those in the latter group.Conculsions The value of CA19-9 in diagnosis of pancreatic cancer is higher than that of CEA.But the combined detection of CA19-9 and CEA is clinically significant to diagnosis of pancreatic cancer.

Key concepts: CA19-9, Medicine, Carcinoembryonic antigen, Pancreatic cancer, Internal medicine, Tumor marker, Gastroenterology, Oncology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Value of Combined Detection of CA19-9 and CEA with Electrochemiluminescence in Diagnosis of Pancreatic Cancer — Research Paper | ScholarLens